Our findings highlight the critical role of a second opinion and in-depth whole genome data analysis in undiagnosed mitochondrial disease cases, underscored by the identification of two compound heterozygous variants in the SUPV3L1 gene in a patient with a unique clinical presentation. Here, SUPV3L1 is linked to mitochondrial disease.